Navigation Links
Mary Hendrickson of GENCO Pharmaceutical Services Speaks Before Senate on the Topic of Drug Take-Back Programs
Date:7/8/2010

Important Issue at Crux of Environment, Drug Regulations, Child/Public Safety and Healthcare Reform

Pittsburgh, PA (Vocus) July 8, 2010 -- GENCO Supply Chain Solutions, North America’s second largest and a Global Top 50 third-party logistics provider, today announced that Mary Hendrickson, Director of Quality and Regulatory Affairs, GENCO Pharmaceutical Services, spoke on June 30 before the U.S. Senate Special Committee on Aging during a hearing on drug waste and disposal. Hendrickson’s testimony transcript and video of the hearing are available on the U.S. Senate Web site. Chairman Kohl (D-WI), along with Senators Corker (R-TN), Collins (R-ME) and Casey (D-PA), attended the hearing. The majority of the witnesses asked for changes to the Controlled Substance Act to allow non-DEA registrants the ability to accept controlled substances through take-back programs. The DEA is on record supporting H.R. 1359 which would give the DEA this authority.

Covered in the testimony is the intersection between drug regulations, environmental concerns and the human tragedy associated with overdoses on prescribed drugs found in medicine cabinets, a human health issue that could have implications within broader healthcare reform initiatives. The panel statements included a drug enforcement official who indicated that a nationwide drug take-back initiative is in the planning stages; a parent who lost a son due to the use of an unused prescription medication left in a medicine cabinet; and among others, Stevan Gressitt, Founding Director, Maine Institute for Safe Medicine, Faculty Associate University of Maine, Center on Aging, who discussed Maine’s statewide program allowing consumers to return unused drugs back to the DEA through the U.S. Postal Service – the program has recovered one ton of unused pharmaceuticals since 2007, saving the state $250,000 per year in associated costs.

Covered in Mary Hendrickson’s statement were the following:

 
  • The environmental and misuse/abuse concerns associated with improper disposal or non-disposal of medications, as often practiced by long term care facilities and in the home.
  • The simple yet highly regulated process of reverse distribution – to waste-to-energy facilities – of unsold medications from pharmacies, of which GENCO Pharmaceutical Services is the leading provider.
  • An overview of the GENCO take-back program in Wisconsin, which allowed for consumers to return unused medications for incineration in a waste-to-energy facility, meeting with great success from both public safety and environmental standpoints. During the six month program, 1,259 households returned 15,164 medications.
  • The process for handling pharmaceutical waste: Incineration of drugs provides an alternative to burning coal for electricity, resulting in a net greenhouse gas reduction, while keeping drugs out of landfills and the water supply. A 2002 U.S. Geological Survey study of 139 bodies of water across the country found that over 80 percent of the water samples were contaminated by prescription drugs, which have been shown to harm fish and wildlife.
  • The barrier to entry for GENCO into a consumer take-back market, despite the company’s standing as the leading provider of reverse distribution for the pharmaceutical industry’s overstocked and expired drugs. The Controlled Substance Act allows only for transfer of controlled substances among the DEA registrants. When a pharmacy dispenses the medication to a patient, the patient is not considered to be within the closed loop of distribution and is not a DEA registrant. As a result, reverse distributors as well as the other DEA registrants cannot take controlled substance product back from patients.

Other experts provided testimony presenting the opinion that the environmental, cost and safety benefits of take-back programs far outweigh the minimal risks of criminal diversion of controlled substances into a black market.

As the leader in pharmaceutical returns for industry, GENCO is well-poised to manage the logistics of a nationwide take-back program. Government’s healthcare reform initiatives may point the nation in the direction of improved data collection regarding the costs associated with over-prescribing, the human tragedy of overdoses associated with the medicine cabinet and the environmental issues with poor disposal – including the issue of medication seepage into the water supply. Legislation reform to address the legislation impeding drug take-back programs is expected over the next two years.

About GENCO Pharmaceutical Services
GENCO Pharmaceutical Services (GPS), a wholly owned subsidiary of GENCO Supply Chain Solutions, is the leader in pharmaceutical trade, sample and clinical trial returns and product recalls. GPS transforms pharmaceutical business activities into data-rich, systematic processes that provide critical business information and value to manufacturers, pharmacies and wholesalers. Through a state-of-the-art processing facility, the company provides comprehensive pharmaceutical returns management services to 67 pharmaceutical manufacturers, the biggest U.S. chain pharmacies, leading wholesalers and mail order pharmacies and specialty and infusion pharmacies. For more information, visit www.gencopharma.com.

About GENCO Supply Chain Solutions
GENCO Supply Chain Solutions is North America's 2nd largest and a Global Top 50 third-party logistics provider and the recognized leader in reverse logistics. The company manages 125 operations and 37 million square feet of warehouse space throughout North America for a diverse range of retail, manufacturing and government customers, including many Fortune 500 companies. The company provides initial and ongoing value through a complete range of solutions, including contract logistics, transportation logistics, parcel negotiation and audits, reverse logistics, damage research, product liquidation, pharmaceutical services, government solutions and supply chain technology solutions. For more information, visit www.genco.com.

###

Read the full story at http://www.prweb.com/releases/2010/07/prweb4237084.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Related medicine news :

1. SDI Reports: Novo Nordisk Takes Top Ranking Among Endocrinologists, According To Pharmaceutical Company Image Study
2. Chinese Biopharmaceutical Association Successfully Holds 15th Annual Conference
3. Omega Design Presented Pharmaceutical Packaging Solutions at the Healthcare Packaging Conference & Workshop 2010
4. HR Pharmaceuticals, Inc. to Launch and Showcase Flagship Product Line at the National Teaching Institute & Critical Care Nurses Exposition
5. Pharmaceutical companies provide EPA 100 drugs to help predict toxicity
6. HIRC Research Alert: New Study Identifies Best Pharmaceutical Company Account Managers and Program Offerings
7. SDI Reports: Pharmaceutical Promotion Spending Indicates Trend Toward Electronic and Online Promotion
8. Impact Systems Successfully Completes EMC Documentum Migration for Global Pharmaceutical Client
9. Sponsoring by the pharmaceutical industry can bias the results of drug studies
10. Jazz Pharmaceuticals to Present at the Barclays Capital 2010 Global Healthcare Conference
11. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2009 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... FL (PRWEB) , ... April 29, 2016 , ... ... will feature Grassland Dairy Products, Inc. in an upcoming episode, airing third quarter ... a century of churning cream into butter, Grassland Dairy Products, located in Greenwood, ...
(Date:4/29/2016)... ... April 29, 2016 , ... Nike Softball Camp at the College of Brockport ... 27th for girls aged 10-18. All facets of the game will be covered; hitting, ... Whited Complex, one of the finest softball facilities in the region. The outstanding professional ...
(Date:4/29/2016)... ... 29, 2016 , ... Coalition Duchenne, a Newport Beach, California ... Duchenne research, participated in the April 25 U.S. Food and Drug Administration advisory ... The meeting at the Marriott Conference Center in Hyattsville, Maryland was attended by ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Pro3rd ... X. Utilize Pixel Film Studios’ lower thirds to introduce people, characters, and locations without ... that include boxes, lines, accents, textures and many more design components. Simply select a ...
(Date:4/29/2016)... ... 29, 2016 , ... Orthodontics Limited, one of the nation’s ... Dr. Middleberg, were asked by Invisalign to present an “Ask the ... titled “Advancing the Biomechanics of Invisalign Clear Aligners,” Dr. Gemmi and Dr. Middleberg ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , April 28, 2016 ... , George Phillips und ... Unternehmens    ArisGlobal®, ein führender ... Sciences, gab heute bekannt, dass neue Führungskräfte ... Unternehmens gestoßen sind, die vielfältige Erfahrungen mitbringen. ...
(Date:4/28/2016)... 2016 Oramed Pharmaceuticals Inc. (NASDAQ: ... focused on the development of oral drug delivery systems, announced ... 2016 conference, presented by Joseph Gunnar & Co. ... New York . Nadav Kidron , CEO of ... Presentation Details:   PIONEERS 2016, presented ...
(Date:4/27/2016)... Mass., April 27, 2016  Hologic, Inc. (Nasdaq: ... financial results for the fiscal second quarter ended ... (EPS) of $0.24 increased 41.2%, and non-GAAP diluted ... million increased 5.8% on a reported basis, and ... "We posted another good quarter, highlighted by ...
Breaking Medicine Technology: